Pronađeno 234 radova, za izraz:
"OSOBA: Igor Aurer (CROSBI Profil: 13608, MBZ: 165536)"
DODAJ/IZMIJENI OPERATORE PRETRAŽIVANJA
FILTRIRANO:
- Vrsta povezanosti: Autorstvo
- Profil osobe: Igor Aurer (13608)
-
1.Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial // Journal of Clinical Oncology, 41 (2023), 2; 327-335 doi:10.1200/jco.21.01281 (međunarodna recenzija, članak, znanstveni)
-
2.Hematologija // Primjeri u kliničkoj medicini / Premužić, Vedran (ur.).
Zagreb: Alfa, 2022. str. 55-73 -
3.The appropriateness of platelet transfusions in hematological patients and the potential for improvement // Transfusion Clinique et Biologique, 31 (2022), 1246-7820, 7 doi:10.1016/j.tracli.2022.11.007 (međunarodna recenzija, članak, znanstveni)
-
4.Relapse patterns in early‐PET negative, limited‐ stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials // British Journal of Haematology, 200 (2022), 18594, 9 doi:10.1111/bjh.18594 (međunarodna recenzija, članak, znanstveni)
-
5.Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem // Biomedicines, 10 (2022), 11; 2892-2902 doi:10.3390/biomedicines10112892 (međunarodna recenzija, članak, znanstveni)
-
6.Tackling Mantle Cell Lymphoma in Europe // Healthcare, 10 (2022), 9; 1682-1691 doi:10.3390/healthcare10091682 (međunarodna recenzija, članak, znanstveni)
-
7.The EHA Research Roadmap: Malignant Lymphoid Diseases // HemaSphere, 6 (2022), 6; e726-e743 doi:10.1097/hs9.0000000000000726 (međunarodna recenzija, članak, znanstveni)
-
8.Reduced steroid exposure is safe and does not reduce disease control among Hodgkin lymphoma patients treated with escalated BEACOPP (eBEACOPP) // 12th International Symposium on Hodgkin Lymphoma
Koln, Njemačka, 2022. str. 8-9 (poster, međunarodna recenzija, sažetak, znanstveni) -
9.Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review // Biomedicines, 10 (2022), 11; 2917, 22 doi:10.3390/biomedicines10112917 (međunarodna recenzija, pregledni rad, znanstveni)
-
10.Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6 doi:10.1097/HS9.0000000000000807 (međunarodna recenzija, članak, znanstveni)
-
11.Bendamustine: a review of pharmacology, clinical use and immunological effects (Review) // Oncology Reports, 47 (2022), 6; 114, 16 doi:10.3892/or.2022.8325 (međunarodna recenzija, pregledni rad, znanstveni)
-
12.Limfomi i upalne bolesti crijeva // Upalne bolesti crijeva / Vucelić, Boris (ur.).
Zagreb: Medicinska naklada, 2021. str. 654-659 -
13.Dose adjusted R-EPOCH and other etoposide- containing regimens in first-line treatment of diffuse large B-cell lymphoma // Acta haematologica polonica, 52 (2021), 325-328 (međunarodna recenzija, članak, znanstveni)
-
14.SerologicResponses following Sars-Cov-2 vaccination and factors influencing it in patients with hematological malignant and non-malignant diseases - a prospective multicentric study // Blood, 138 (2021), Suppl 1
Atlanta, SAD, 2021. str. 47-49 doi:10.1182/blood-2021-153573 (poster, međunarodna recenzija, prošireni sažetak, znanstveni) -
15.The impact of achieving complete remission prior to allogeneic stem cell transplantation on progression-free survival in Hodgkin lymphoma // Clinical Hematology International, 3 (2021), 116-118 doi:10.2991/chi.k.210704.002 ; eISSN 2590-0048 (međunarodna recenzija, članak, znanstveni)
-
16.Prevencija i liječenje mukozitisa u bolesnika sa zloćudnim hematološkim bolestima: pregled područja i stav Hrvatske kooperativne grupe za hematološke bolesti (KROHEM). // Medicina Fluminensis, 57 (2021), 4; 373-383 doi:10.21860/medflum2021_264893 (domaća recenzija, pregledni rad, znanstveni)
-
17.Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non internventional study of the Croatian Cooperative Group for Hematologic Diseases // Croatian medical journal, 62 (2021), 5; 455-463 doi:10.3325/cmj.2021.62.455-63 (međunarodna recenzija, članak, znanstveni)
-
18.Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma // European journal of cancer (1990), 157 (2021), 132-139 doi:10.1016/j.ejca.2021.08.005 (međunarodna recenzija, članak, znanstveni)
-
19.EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic // HemaSphere, 5 (2021), 2; e529-e631 doi:10.1097/HS9.0000000000000529 (međunarodna recenzija, pregledni rad, znanstveni)
-
20.COVID-19 u hematoloških bolesnika – analiza Krohema (5/2021) // Bilten Krohema, 13 (2021), 2; 3-4 (podatak o recenziji nije dostupan, osvrt, znanstveni)
-
21.Purine analogues increase the risk of lethal and/or prolonged COVID19 while obinutuzumab increases the risk of prolonged but not lethal infection in patients treated for lymphoid malignancies - a study of Krohem, the Croatian group for hematologic diseases // Blood, 138 (2021), Suppl 1
Atlanta, SAD, 2021. str. 3553-3553 doi:10.1182/blood-2021-149613 (poster, međunarodna recenzija, sažetak, znanstveni) -
22.Prikupljanje i krioprezervacija autolognih mononuklearnih stanica iz periferne krvi za potrebe proizvodnje car-t stanica // 8. Hrvatski transfuziološki kongres i 7. stručni sastanak medicinskih sestara i tehničara u transfuzijskoj medicini
Zagreb, 2021. str. 118-119 (poster, podatak o recenziji nije dostupan, sažetak, ostalo) -
23.Indikacije i učinkovitost liječenja hospitaliziranih hematoloških bolesnika koncentratima trombocita // 8. Hrvatski transfuziološki kongres i 7. stručni sastanak medicinskih sestara i tehničara u transfuzijskoj medicini
Zagreb, 2021. str. 83-84 (predavanje, podatak o recenziji nije dostupan, sažetak, ostalo) -
24.Comparison of Different Schedules of Rituximab and Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of Krohem // Journal of Cancer Science and Clinical Therapeutics, 05 (2021), 04; 426-433 doi:10.26502/jcsct.5079128 (međunarodna recenzija, članak, ostalo)
-
25.Recurrence of Tumor Flare Reaction in a Chronic Lymphocytic Leukemia Patient During ChlorambucilRituximab Treatment 6 Years After Lenalidomide // Open Access Journal of Biomedical Science, 4 (2021), 3; 1008-1909 doi:10.38125/oajbs.000310 (međunarodna recenzija, članak, znanstveni)
